Skip to content
Screener

AtriCure ATRC Total Equity

Total Equity at other companies

Abbott logo
AbbottABT
$51.11B+1.1%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$84.97B+8.3%
Boston Scientific logo
Boston ScientificBSX
$25.86B+16.4%
Medtronic logo
MedtronicMDT
$49.46B+3.0%
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
$99.5M-4.8%
Artivion logo
ArtivionAORT
$445.59M+6.1%

Other financials

Income statement

See full
Revenue$153.6M+12.8%
Gross profit$118.6M+16.9%
Operating income$9.7M+256%
Net income$9.0M+245%
EPS (diluted)$0.18+238%

Balance sheet

See full
Cash & equivalents$167.8M+42.4%
Total debt$75.5M-3.8%
Total assets$676.6M+11.1%

Cash flow

See full
Operating cash flow$22.2M+2.7%
CapEx$3.8M+41.5%
Free cash flow$18.4M-2.8%

Valuation

See full
Market cap$2.01B+10.7%
Enterprise value$1.92B+7.9%
P/E770.8×
P/S3.5×-0.1×

Profitability

See full
Gross margin76.3%+1.6pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.3%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.1×0.0×
Current ratio4.2×+0.3×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: AtriCure’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 1:07 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001323885-26-000035
Line itemJune 30,2026December 31,2025
Commitments and contingencies (Note 8)
Stockholders’ Equity:
Common stock, $0.001 par value, 90,000 shares authorized and 50,863 and 49,792 issued and outstanding5150
Additional paid-in capital920,421904,522
Accumulated other comprehensive income101566
Accumulated deficit(404,140)(413,203)
Total Stockholders’ Equity516,433491,935
Total Liabilities and Stockholders’ Equity$676,643$654,179

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is AtriCure's total equity?
AtriCure (ATRC) reported total equity of $516.43M in Q2 2026.
How has AtriCure's total equity changed year-over-year?
AtriCure's total equity increased by 11.2% year-over-year, from $464.49M to $516.43M.
What is the long-term trend for AtriCure's total equity?
Over 5 years (2020 to 2025), AtriCure's total equity has grown at a 3.6% compound annual growth rate (CAGR), from $412.39M to $491.94M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about AtriCure's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude